Infantile-onset Neuronal Ceroid Lipofuscinosis (INCL) is a severe pediatric neurodegenerative disorder produced by mutations in the gene encoding palmitoyl-protein thioesterase 1 (Ppt1). This enzyme is responsible for the removal of a palmitate post-translational modification from an unknown set of substrate proteins. To better understand the function of Ppt1 in neurons, we performed an unbiased dominant loss-offunction genetic modifier screen in Drosophila using a previously characterized Ppt1 gain-of-function system. The enhancers and suppressors identified in our screen make novel connections between Ppt1 and genes involved in cellular trafficking and the modulation of synaptic growth. We further support the relevance of our screen by demonstrating that Garland cells from Ppt1 loss-of-function mutants have defects in endocytic trafficking. Endocytic tracer uptake and ultrastructural analysis of these non-neuronal cells points to Ppt1 playing a role in modulating the early stages of vesicle formation. This work lays the groundwork for further experimental exploration of these processes to better understand their contributions to the INCL disease process.
Introduction
The Neuronal Ceroid Lipofuscinoses (NCL) are a group of primarily recessive neurodegenerative disorders characterized by regionally specific neurodegeneration in the retina, cortex, and cerebellum (Haltia, 2006) . Commonly known as Batten Disease, the loss of major neuronal populations leads to clinical symptoms that include epilepsy, sleep disorders, ataxia, blindness and progressive mental and physical decline (Williams et al., 2006) . There are 10 identified forms, each of which is characterized by the presence of lipofuscinlike pathology, distinct lysosomal inclusion pathology and differing age of onset (Haltia, 2006; Williams et al., 2006) . Patients with the infantile onset form begin to show atrophy of the cortex and cerebellum by 13 months of age, culminating in a substantial loss of neurons at the time of death (Mitchison et al., 1998; van Diggelen et al., 2001; Wisniewski, 2005; Williams et al., 2006) .
Infantile NCL is caused by mutations in the CLN1 gene that encodes the soluble lysosomal enzyme, palmitoyl-protein thioesterase 1 (PPT1) (Vesa et al., 1995) . Palmitoylation is a dynamic posttranslational modification of proteins in which a 16-carbon palmitate moiety is covalently attached to cysteine residues found in cytoplasmic and integral membrane proteins. (Nadolski and Linder, 2007) . This lipidation event plays an important regulatory role for modulating protein trafficking and localization, vesicle fusion, and signal transduction mechanisms (el-Husseini and Bredt, 2002; Nadolski and Linder, 2007) . Ppt1 is one of the enzymes that can remove this lipid modification from specific substrates during protein degradation within the lysosomes. The enzyme is present in all cell types, but only neuronal cells undergo cell death suggesting that there is an important role for palmitoylation in normal neuronal function (Isosomppi et al., 1999; Suopanki et al., 1999a,b; Zhang et al., 1999) .
Work on several different NCL models has shown that the location and density of intracellular inclusions within the brain does not necessarily correlate with the ultimate loss of neuronal cells (Bible et al., 2004; Oswald et al., 2005) . Thus, a more in depth understanding of the cellular location and function of the Ppt1 protein will likely inform our understanding of the particular pathways and processes which, when perturbed, lead to the neuronal dysfunction typical of the disease. The fruit fly has been a powerful model system for studying neurological disorders including lysosomal storage disorders like the NCLs (reviewed in Muqit and Feany, 2002; Myllykangas et al., 2005 (Ctsd) ; Hickey et al., 2006 (Ppt1); Kuronen et al., 2009 (Ctsd); Tuxworth et al., 2009 (Cln3) ). Loss-of-function Ppt1 mutations have been generated in Drosophila that produce cytoplasmic inclusions and autoflourescent storage material (Hickey et al., 2006) . In addition to loss of function approaches, we have also produced an overexpression model of Ppt1 function in the adult visual system that was the basis for a previously reported dominant gain-of-function genetic modifier screen that implicated specific pathways and proteins as points of potential in vivo regulation by Ppt1's depalmitoylating activity (Korey and MacDonald, 2003; Buff et al., 2007) . 
